Bio Insight Bio Analysis
Patent Wars and Patient Lives: Inside Roche vs Natco Over Risdiplam
In a courtroom packed with legal heavyweights, global pharmaceutical giant F. Hoffmann-La Roche AG faced off against Indian generic manufac...
April 14, 2025 | Analysis
RNA Therapeutics 2024: From Pandemic Pivots to Precision Powerhouses
2024 marked a transformative year for RNA therapeutics. What began as a pandemic-driven innovation sprint has evolved into a diversified, multi-platform fr...
April 03, 2025 | Analysis
2025 Pharma and Medical Device Trends for Manufacturing Leaders
2025 Pharma and Medical Device Trends for Manufacturing LeadersKey Insights for Regulated Manufacturing Today and Tomorrow In ...
January 07, 2025 | News
Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
Antibody-Drug Conjugates (ADCs) represent a paradigm shift in oncology, offering targeted cancer treatment that minimizes collateral damage to healthy cell...
December 23, 2024 | News
BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
The Asia-Pacific (APAC) region is rapidly emerging as a global powerhouse in the biopharmaceutical industry. This growth is fueled by a combination of inno...
December 20, 2024 | Analysis
IPO Renaissance: Biopharma's Strategic Momentum Sets the Stage for 2025
The IPO class of 2024 has redefined the biopharma and life sciences landscape, marking a return to growth after a prolonged period of market caution. These...
November 27, 2024 | Report
Breaking Down Portal Fatigue in Cell and Gene Therapy: Insights from TrakCel’s Experts
In this exclusive BioPharma APAC Q&A, Dr. Matthew Lakelin, Co-Founder and Head of Consultancy Services at TrakCel, and Antonios Spanos, Industry Adviso...
October 17, 2024 | Interview
Cervical Cancer Screenings Drop Among Commercially Insured Women, Analysis Reveals Alarming Decline in Lifesaving Tests
The number of women getting recommended cervical cancer screenings is declining, according to data from Cedar Gate Technologies’ proprietary Nat...
January 18, 2024 | Analysis
Biotech and Biopharma Industry Trends: What to Watch for in 2024
In a year-round up preview, Dr. Senthil Sockalingam, Head of IQVIA Biotech in Japan-Asia Pacific and Chief Medical Officer of IQVIA Asia Pacific, offers a ...
December 18, 2023 | Opinion | By Dr Senthil Sockalingam, Head, IQVIA Biotech in Japan-Asia Pacific; Chief Medical Officer, IQVIA Asia Pacific
BGI Genomics Global Cervical Cancer Survey Finds Young Women Have Higher Vaccination Rates but 43.5 percent Put off by Pap Smears
To further inform action to combat cervical cancer, the fourth most common cancer among women globally, BGI Genomics released its State of Cervi...
July 24, 2023 | News
Cytiva launches 2023 Biopharma Resilience Index
Industry leaders rate capabilities in five key areas: supply chain resilience, talent pool, R&D ecosystem, manufacturing agility, and government poli...
June 20, 2023 | Analysis
Agilent Reports Second-Quarter Fiscal Year 2023 Financial Results
Highlights: Revenue of $1.72 billion represents 6.8% reported growth year-over-year; and up 9.5% on a core(1) basis. GAAP net income of $302...
May 24, 2023 | News
Pfizer urges awareness of life-threatening ATTR-CM disease
ATTR-CM is caused by unstable transthyretin proteins that misfold and aggregate into amyloid fibrils that build up in the heart and other parts of the body...
May 12, 2023 | Analysis
The Impact of Digital Health Technologies in Oncology: Current State and Future Directions
Digital health has revolutionized the way healthcare is delivered and managed in recent years. Oncology is one field that has benefited significantly from ...
May 03, 2023 | Opinion
Most Read
- Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
